|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
1 | AN ACT concerning professional regulation.
| |||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||||||
4 | Section 5. The Physician Assistant Practice Act of 1987 is | |||||||||||||||||||||||
5 | amended by changing Section 7.5 as follows:
| |||||||||||||||||||||||
6 | (225 ILCS 95/7.5)
| |||||||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2018)
| |||||||||||||||||||||||
8 | Sec. 7.5. Prescriptions. A physician assistant may | |||||||||||||||||||||||
9 | prescribe, dispense, and administer drugs and medical devices | |||||||||||||||||||||||
10 | to the extent delegated by the supervising physician. | |||||||||||||||||||||||
11 | Prescribing and dispensing of drugs may include Schedule II | |||||||||||||||||||||||
12 | through V controlled substances as described in Article II of | |||||||||||||||||||||||
13 | the Illinois Controlled Substances Act and all legend drugs.
| |||||||||||||||||||||||
14 | All dispensing activities of any physician assistant shall: | |||||||||||||||||||||||
15 | (1) comply with appropriate federal and State | |||||||||||||||||||||||
16 | regulations; and | |||||||||||||||||||||||
17 | (2) occur when pharmacy services are not reasonably | |||||||||||||||||||||||
18 | available, or when it is in the best interest of the | |||||||||||||||||||||||
19 | patient, or when it is an emergency. Physician assistants | |||||||||||||||||||||||
20 | may request, receive, and sign for professional samples and | |||||||||||||||||||||||
21 | may distribute professional samples to patients. A | |||||||||||||||||||||||
22 | supervising physician may delegate
limited prescriptive | |||||||||||||||||||||||
23 | authority to a physician assistant.
This authority may, but |
| |||||||
| |||||||
1 | is not required to, include prescription and
dispensing of | ||||||
2 | legend
drugs and legend controlled substances categorized | ||||||
3 | as Schedule III, IV, or V
controlled substances, as defined | ||||||
4 | in Article II of the Illinois Controlled
Substances Act, as | ||||||
5 | delegated in the written guidelines required by this
Act. | ||||||
6 | To prescribe Schedule III, IV, or V controlled substances | ||||||
7 | under this
Section, a physician assistant must obtain a | ||||||
8 | mid-level practitioner
controlled substances license. | ||||||
9 | Medication orders issued by a
physician
assistant shall be | ||||||
10 | reviewed
periodically by the supervising physician. The | ||||||
11 | supervising physician shall file
with the Department notice of | ||||||
12 | delegation of prescriptive authority to a
physician assistant | ||||||
13 | and
termination of delegation, specifying the authority | ||||||
14 | delegated or terminated.
Upon receipt of this notice delegating | ||||||
15 | authority to prescribe Schedule III,
IV, or V controlled | ||||||
16 | substances, the physician assistant shall be eligible to
| ||||||
17 | register for a mid-level practitioner controlled substances | ||||||
18 | license under
Section 303.05 of the Illinois Controlled | ||||||
19 | Substances Act.
Nothing in this Act shall be construed to limit | ||||||
20 | the delegation of tasks or
duties by the supervising physician | ||||||
21 | to a nurse or other appropriately trained
personnel.
| ||||||
22 | The Department shall establish by rule the minimum | ||||||
23 | requirements for
written guidelines to be followed under this | ||||||
24 | Section.
| ||||||
25 | (Source: P.A. 90-116, eff. 7-14-97; 90-818, eff. 3-23-99 .)
|
| |||||||
| |||||||
1 | Section 10. The Illinois Controlled Substances Act is | ||||||
2 | amended by changing Sections 102 and 303.05 as follows: | ||||||
3 | (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | ||||||
4 | Sec. 102. Definitions. As used in this Act, unless the | ||||||
5 | context
otherwise requires:
| ||||||
6 | (a) "Addict" means any person who habitually uses any drug, | ||||||
7 | chemical,
substance or dangerous drug other than alcohol so as | ||||||
8 | to endanger the public
morals, health, safety or welfare or who | ||||||
9 | is so far addicted to the use of a
dangerous drug or controlled | ||||||
10 | substance other than alcohol as to have lost
the power of self | ||||||
11 | control with reference to his addiction.
| ||||||
12 | (b) "Administer" means the direct application of a | ||||||
13 | controlled
substance, whether by injection, inhalation, | ||||||
14 | ingestion, or any other
means, to the body of a patient, | ||||||
15 | research subject, or animal (as
defined by the Humane | ||||||
16 | Euthanasia in Animal Shelters Act) by:
| ||||||
17 | (1) a practitioner (or, in his presence, by his | ||||||
18 | authorized agent),
| ||||||
19 | (2) the patient or research subject at the lawful | ||||||
20 | direction of the
practitioner, or
| ||||||
21 | (3) a euthanasia technician as defined by the Humane | ||||||
22 | Euthanasia in
Animal Shelters Act.
| ||||||
23 | (c) "Agent" means an authorized person who acts on behalf | ||||||
24 | of or at
the direction of a manufacturer, distributor, or | ||||||
25 | dispenser. It does not
include a common or contract carrier, |
| |||||||
| |||||||
1 | public warehouseman or employee of
the carrier or warehouseman.
| ||||||
2 | (c-1) "Anabolic Steroids" means any drug or hormonal | ||||||
3 | substance,
chemically and pharmacologically related to | ||||||
4 | testosterone (other than
estrogens, progestins, and | ||||||
5 | corticosteroids) that promotes muscle growth,
and includes:
| ||||||
6 | (i) boldenone,
| ||||||
7 | (ii) chlorotestosterone,
| ||||||
8 | (iii) chostebol,
| ||||||
9 | (iv) dehydrochlormethyltestosterone,
| ||||||
10 | (v) dihydrotestosterone,
| ||||||
11 | (vi) drostanolone,
| ||||||
12 | (vii) ethylestrenol,
| ||||||
13 | (viii) fluoxymesterone,
| ||||||
14 | (ix) formebulone,
| ||||||
15 | (x) mesterolone,
| ||||||
16 | (xi) methandienone,
| ||||||
17 | (xii) methandranone,
| ||||||
18 | (xiii) methandriol,
| ||||||
19 | (xiv) methandrostenolone,
| ||||||
20 | (xv) methenolone,
| ||||||
21 | (xvi) methyltestosterone,
| ||||||
22 | (xvii) mibolerone,
| ||||||
23 | (xviii) nandrolone,
| ||||||
24 | (xix) norethandrolone,
| ||||||
25 | (xx) oxandrolone,
| ||||||
26 | (xxi) oxymesterone,
|
| |||||||
| |||||||
1 | (xxii) oxymetholone,
| ||||||
2 | (xxiii) stanolone,
| ||||||
3 | (xxiv) stanozolol,
| ||||||
4 | (xxv) testolactone,
| ||||||
5 | (xxvi) testosterone,
| ||||||
6 | (xxvii) trenbolone, and
| ||||||
7 | (xxviii) any salt, ester, or isomer of a drug or | ||||||
8 | substance described
or listed in this paragraph, if | ||||||
9 | that salt, ester, or isomer promotes muscle
growth.
| ||||||
10 | Any person who is otherwise lawfully in possession of an | ||||||
11 | anabolic
steroid, or who otherwise lawfully manufactures, | ||||||
12 | distributes, dispenses,
delivers, or possesses with intent to | ||||||
13 | deliver an anabolic steroid, which
anabolic steroid is | ||||||
14 | expressly intended for and lawfully allowed to be
administered | ||||||
15 | through implants to livestock or other nonhuman species, and
| ||||||
16 | which is approved by the Secretary of Health and Human Services | ||||||
17 | for such
administration, and which the person intends to | ||||||
18 | administer or have
administered through such implants, shall | ||||||
19 | not be considered to be in
unauthorized possession or to | ||||||
20 | unlawfully manufacture, distribute, dispense,
deliver, or | ||||||
21 | possess with intent to deliver such anabolic steroid for
| ||||||
22 | purposes of this Act.
| ||||||
23 | (d) "Administration" means the Drug Enforcement | ||||||
24 | Administration,
United States Department of Justice, or its | ||||||
25 | successor agency.
| ||||||
26 | (e) "Control" means to add a drug or other substance, or |
| |||||||
| |||||||
1 | immediate
precursor, to a Schedule under Article II of this Act | ||||||
2 | whether by
transfer from another Schedule or otherwise.
| ||||||
3 | (f) "Controlled Substance" means a drug, substance, or | ||||||
4 | immediate
precursor in the Schedules of Article II of this Act.
| ||||||
5 | (g) "Counterfeit substance" means a controlled substance, | ||||||
6 | which, or
the container or labeling of which, without | ||||||
7 | authorization bears the
trademark, trade name, or other | ||||||
8 | identifying mark, imprint, number or
device, or any likeness | ||||||
9 | thereof, of a manufacturer, distributor, or
dispenser other | ||||||
10 | than the person who in fact manufactured, distributed,
or | ||||||
11 | dispensed the substance.
| ||||||
12 | (h) "Deliver" or "delivery" means the actual, constructive | ||||||
13 | or
attempted transfer of possession of a controlled substance, | ||||||
14 | with or
without consideration, whether or not there is an | ||||||
15 | agency relationship.
| ||||||
16 | (i) "Department" means the Illinois Department of Human | ||||||
17 | Services (as
successor to the Department of Alcoholism and | ||||||
18 | Substance Abuse) or its successor agency.
| ||||||
19 | (j) "Department of State Police" means the Department of | ||||||
20 | State
Police of the State of Illinois or its successor agency.
| ||||||
21 | (k) "Department of Corrections" means the Department of | ||||||
22 | Corrections
of the State of Illinois or its successor agency.
| ||||||
23 | (l) "Department of Professional Regulation" means the | ||||||
24 | Department
of Professional Regulation of the State of Illinois | ||||||
25 | or its successor agency.
| ||||||
26 | (m) "Depressant" or "stimulant substance" means:
|
| |||||||
| |||||||
1 | (1) a drug which contains any quantity of (i) | ||||||
2 | barbituric acid or
any of the salts of barbituric acid | ||||||
3 | which has been designated as habit
forming under section | ||||||
4 | 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 | ||||||
5 | U.S.C. 352 (d)); or
| ||||||
6 | (2) a drug which contains any quantity of (i) | ||||||
7 | amphetamine or
methamphetamine and any of their optical | ||||||
8 | isomers; (ii) any salt of
amphetamine or methamphetamine or | ||||||
9 | any salt of an optical isomer of
amphetamine; or (iii) any | ||||||
10 | substance which the Department, after
investigation, has | ||||||
11 | found to be, and by rule designated as, habit forming
| ||||||
12 | because of its depressant or stimulant effect on the | ||||||
13 | central nervous
system; or
| ||||||
14 | (3) lysergic acid diethylamide; or
| ||||||
15 | (4) any drug which contains any quantity of a substance | ||||||
16 | which the
Department, after investigation, has found to | ||||||
17 | have, and by rule
designated as having, a potential for | ||||||
18 | abuse because of its depressant or
stimulant effect on the | ||||||
19 | central nervous system or its hallucinogenic
effect.
| ||||||
20 | (n) (Blank).
| ||||||
21 | (o) "Director" means the Director of the Department of | ||||||
22 | State Police or
the Department of Professional Regulation or | ||||||
23 | his designated agents.
| ||||||
24 | (p) "Dispense" means to deliver a controlled substance to | ||||||
25 | an
ultimate user or research subject by or pursuant to the | ||||||
26 | lawful order of
a prescriber, including the prescribing, |
| |||||||
| |||||||
1 | administering, packaging,
labeling, or compounding necessary | ||||||
2 | to prepare the substance for that
delivery.
| ||||||
3 | (q) "Dispenser" means a practitioner who dispenses.
| ||||||
4 | (r) "Distribute" means to deliver, other than by | ||||||
5 | administering or
dispensing, a controlled substance.
| ||||||
6 | (s) "Distributor" means a person who distributes.
| ||||||
7 | (t) "Drug" means (1) substances recognized as drugs in the | ||||||
8 | official
United States Pharmacopoeia, Official Homeopathic | ||||||
9 | Pharmacopoeia of the
United States, or official National | ||||||
10 | Formulary, or any supplement to any
of them; (2) substances | ||||||
11 | intended for use in diagnosis, cure, mitigation,
treatment, or | ||||||
12 | prevention of disease in man or animals; (3) substances
(other | ||||||
13 | than food) intended to affect the structure of any function of
| ||||||
14 | the body of man or animals and (4) substances intended for use | ||||||
15 | as a
component of any article specified in clause (1), (2), or | ||||||
16 | (3) of this
subsection. It does not include devices or their | ||||||
17 | components, parts, or
accessories.
| ||||||
18 | (t-5) "Euthanasia agency" means
an entity certified by the | ||||||
19 | Department of Professional Regulation for the
purpose of animal | ||||||
20 | euthanasia that holds an animal control facility license or
| ||||||
21 | animal
shelter license under the Animal Welfare Act. A | ||||||
22 | euthanasia agency is
authorized to purchase, store, possess, | ||||||
23 | and utilize Schedule II nonnarcotic and
Schedule III | ||||||
24 | nonnarcotic drugs for the sole purpose of animal euthanasia.
| ||||||
25 | (t-10) "Euthanasia drugs" means Schedule II or Schedule III | ||||||
26 | substances
(nonnarcotic controlled substances) that are used |
| |||||||
| |||||||
1 | by a euthanasia agency for
the purpose of animal euthanasia.
| ||||||
2 | (u) "Good faith" means the prescribing or dispensing of a | ||||||
3 | controlled
substance by a practitioner in the regular course of | ||||||
4 | professional
treatment to or for any person who is under his | ||||||
5 | treatment for a
pathology or condition other than that | ||||||
6 | individual's physical or
psychological dependence upon or | ||||||
7 | addiction to a controlled substance,
except as provided herein: | ||||||
8 | and application of the term to a pharmacist
shall mean the | ||||||
9 | dispensing of a controlled substance pursuant to the
| ||||||
10 | prescriber's order which in the professional judgment of the | ||||||
11 | pharmacist
is lawful. The pharmacist shall be guided by | ||||||
12 | accepted professional
standards including, but not limited to | ||||||
13 | the following, in making the
judgment:
| ||||||
14 | (1) lack of consistency of doctor-patient | ||||||
15 | relationship,
| ||||||
16 | (2) frequency of prescriptions for same drug by one | ||||||
17 | prescriber for
large numbers of patients,
| ||||||
18 | (3) quantities beyond those normally prescribed,
| ||||||
19 | (4) unusual dosages,
| ||||||
20 | (5) unusual geographic distances between patient, | ||||||
21 | pharmacist and
prescriber,
| ||||||
22 | (6) consistent prescribing of habit-forming drugs.
| ||||||
23 | (u-1) "Home infusion services" means services provided by a | ||||||
24 | pharmacy in
compounding solutions for direct administration to | ||||||
25 | a patient in a private
residence, long-term care facility, or | ||||||
26 | hospice setting by means of parenteral,
intravenous, |
| |||||||
| |||||||
1 | intramuscular, subcutaneous, or intraspinal infusion.
| ||||||
2 | (v) "Immediate precursor" means a substance:
| ||||||
3 | (1) which the Department has found to be and by rule | ||||||
4 | designated as
being a principal compound used, or produced | ||||||
5 | primarily for use, in the
manufacture of a controlled | ||||||
6 | substance;
| ||||||
7 | (2) which is an immediate chemical intermediary used or | ||||||
8 | likely to
be used in the manufacture of such controlled | ||||||
9 | substance; and
| ||||||
10 | (3) the control of which is necessary to prevent, | ||||||
11 | curtail or limit
the manufacture of such controlled | ||||||
12 | substance.
| ||||||
13 | (w) "Instructional activities" means the acts of teaching, | ||||||
14 | educating
or instructing by practitioners using controlled | ||||||
15 | substances within
educational facilities approved by the State | ||||||
16 | Board of Education or
its successor agency.
| ||||||
17 | (x) "Local authorities" means a duly organized State, | ||||||
18 | County or
Municipal peace unit or police force.
| ||||||
19 | (y) "Look-alike substance" means a substance, other than a | ||||||
20 | controlled
substance which (1) by overall dosage unit | ||||||
21 | appearance, including shape,
color, size, markings or lack | ||||||
22 | thereof, taste, consistency, or any other
identifying physical | ||||||
23 | characteristic of the substance, would lead a reasonable
person | ||||||
24 | to believe that the substance is a controlled substance, or (2) | ||||||
25 | is
expressly or impliedly represented to be a controlled | ||||||
26 | substance or is
distributed under circumstances which would |
| |||||||
| |||||||
1 | lead a reasonable person to
believe that the substance is a | ||||||
2 | controlled substance. For the purpose of
determining whether | ||||||
3 | the representations made or the circumstances of the
| ||||||
4 | distribution would lead a reasonable person to believe the | ||||||
5 | substance to be
a controlled substance under this clause (2) of | ||||||
6 | subsection (y), the court or
other authority may consider the | ||||||
7 | following factors in addition to any other
factor that may be | ||||||
8 | relevant:
| ||||||
9 | (a) statements made by the owner or person in control | ||||||
10 | of the substance
concerning its nature, use or effect;
| ||||||
11 | (b) statements made to the buyer or recipient that the | ||||||
12 | substance may
be resold for profit;
| ||||||
13 | (c) whether the substance is packaged in a manner | ||||||
14 | normally used for the
illegal distribution of controlled | ||||||
15 | substances;
| ||||||
16 | (d) whether the distribution or attempted distribution | ||||||
17 | included an
exchange of or demand for money or other | ||||||
18 | property as consideration, and
whether the amount of the | ||||||
19 | consideration was substantially greater than the
| ||||||
20 | reasonable retail market value of the substance.
| ||||||
21 | Clause (1) of this subsection (y) shall not apply to a | ||||||
22 | noncontrolled
substance in its finished dosage form that was | ||||||
23 | initially introduced into
commerce prior to the initial | ||||||
24 | introduction into commerce of a controlled
substance in its | ||||||
25 | finished dosage form which it may substantially resemble.
| ||||||
26 | Nothing in this subsection (y) prohibits the dispensing or |
| |||||||
| |||||||
1 | distributing
of noncontrolled substances by persons authorized | ||||||
2 | to dispense and
distribute controlled substances under this | ||||||
3 | Act, provided that such action
would be deemed to be carried | ||||||
4 | out in good faith under subsection (u) if the
substances | ||||||
5 | involved were controlled substances.
| ||||||
6 | Nothing in this subsection (y) or in this Act prohibits the | ||||||
7 | manufacture,
preparation, propagation, compounding, | ||||||
8 | processing, packaging, advertising
or distribution of a drug or | ||||||
9 | drugs by any person registered pursuant to
Section 510 of the | ||||||
10 | Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
| ||||||
11 | (y-1) "Mail-order pharmacy" means a pharmacy that is | ||||||
12 | located in a state
of the United States, other than Illinois, | ||||||
13 | that delivers, dispenses or
distributes, through the United | ||||||
14 | States Postal Service or other common
carrier, to Illinois | ||||||
15 | residents, any substance which requires a prescription.
| ||||||
16 | (z) "Manufacture" means the production, preparation, | ||||||
17 | propagation,
compounding, conversion or processing of a | ||||||
18 | controlled substance other than methamphetamine, either
| ||||||
19 | directly or indirectly, by extraction from substances of | ||||||
20 | natural origin,
or independently by means of chemical | ||||||
21 | synthesis, or by a combination of
extraction and chemical | ||||||
22 | synthesis, and includes any packaging or
repackaging of the | ||||||
23 | substance or labeling of its container, except that
this term | ||||||
24 | does not include:
| ||||||
25 | (1) by an ultimate user, the preparation or compounding | ||||||
26 | of a
controlled substance for his own use; or
|
| |||||||
| |||||||
1 | (2) by a practitioner, or his authorized agent under | ||||||
2 | his
supervision, the preparation, compounding, packaging, | ||||||
3 | or labeling of a
controlled substance:
| ||||||
4 | (a) as an incident to his administering or | ||||||
5 | dispensing of a
controlled substance in the course of | ||||||
6 | his professional practice; or
| ||||||
7 | (b) as an incident to lawful research, teaching or | ||||||
8 | chemical
analysis and not for sale.
| ||||||
9 | (z-1) (Blank).
| ||||||
10 | (aa) "Narcotic drug" means any of the following, whether | ||||||
11 | produced
directly or indirectly by extraction from substances | ||||||
12 | of natural origin,
or independently by means of chemical | ||||||
13 | synthesis, or by a combination of
extraction and chemical | ||||||
14 | synthesis:
| ||||||
15 | (1) opium and opiate, and any salt, compound, | ||||||
16 | derivative, or
preparation of opium or opiate;
| ||||||
17 | (2) any salt, compound, isomer, derivative, or | ||||||
18 | preparation thereof
which is chemically equivalent or | ||||||
19 | identical with any of the substances
referred to in clause | ||||||
20 | (1), but not including the isoquinoline alkaloids
of opium;
| ||||||
21 | (3) opium poppy and poppy straw;
| ||||||
22 | (4) coca leaves and any salts, compound, isomer, salt | ||||||
23 | of an isomer,
derivative, or preparation of coca leaves | ||||||
24 | including cocaine or ecgonine,
and any salt, compound, | ||||||
25 | isomer, derivative, or preparation thereof which is
| ||||||
26 | chemically equivalent or identical with any of these |
| |||||||
| |||||||
1 | substances, but not
including decocainized coca leaves or | ||||||
2 | extractions of coca leaves which do
not contain cocaine or | ||||||
3 | ecgonine (for the purpose of this paragraph, the
term | ||||||
4 | "isomer" includes optical, positional and geometric | ||||||
5 | isomers).
| ||||||
6 | (bb) "Nurse" means a registered nurse licensed under the
| ||||||
7 | Nurse Practice Act.
| ||||||
8 | (cc) (Blank).
| ||||||
9 | (dd) "Opiate" means any substance having an addiction | ||||||
10 | forming or
addiction sustaining liability similar to morphine | ||||||
11 | or being capable of
conversion into a drug having addiction | ||||||
12 | forming or addiction sustaining
liability.
| ||||||
13 | (ee) "Opium poppy" means the plant of the species Papaver
| ||||||
14 | somniferum L., except its seeds.
| ||||||
15 | (ff) "Parole and Pardon Board" means the Parole and Pardon | ||||||
16 | Board of
the State of Illinois or its successor agency.
| ||||||
17 | (gg) "Person" means any individual, corporation, | ||||||
18 | mail-order pharmacy,
government or governmental subdivision or | ||||||
19 | agency, business trust, estate,
trust, partnership or | ||||||
20 | association, or any other entity.
| ||||||
21 | (hh) "Pharmacist" means any person who holds a license or | ||||||
22 | certificate of
registration as a registered pharmacist, a local | ||||||
23 | registered pharmacist
or a registered assistant pharmacist | ||||||
24 | under the Pharmacy Practice Act.
| ||||||
25 | (ii) "Pharmacy" means any store, ship or other place in | ||||||
26 | which
pharmacy is authorized to be practiced under the Pharmacy |
| |||||||
| |||||||
1 | Practice Act.
| ||||||
2 | (jj) "Poppy straw" means all parts, except the seeds, of | ||||||
3 | the opium
poppy, after mowing.
| ||||||
4 | (kk) "Practitioner" means a physician licensed to practice | ||||||
5 | medicine in all
its branches, dentist, optometrist, | ||||||
6 | podiatrist,
veterinarian, scientific investigator, pharmacist, | ||||||
7 | physician assistant,
advanced practice nurse,
licensed | ||||||
8 | practical
nurse, registered nurse, hospital, laboratory, or | ||||||
9 | pharmacy, or other
person licensed, registered, or otherwise | ||||||
10 | lawfully permitted by the
United States or this State to | ||||||
11 | distribute, dispense, conduct research
with respect to, | ||||||
12 | administer or use in teaching or chemical analysis, a
| ||||||
13 | controlled substance in the course of professional practice or | ||||||
14 | research.
| ||||||
15 | (ll) "Pre-printed prescription" means a written | ||||||
16 | prescription upon which
the designated drug has been indicated | ||||||
17 | prior to the time of issuance.
| ||||||
18 | (mm) "Prescriber" means a physician licensed to practice | ||||||
19 | medicine in all
its branches, dentist, optometrist, podiatrist | ||||||
20 | or
veterinarian who issues a prescription, a physician | ||||||
21 | assistant who
issues a
prescription for a Schedule III, IV, or | ||||||
22 | V controlled substance
in accordance
with Section 303.05 and | ||||||
23 | the written guidelines required under Section 7.5
of the
| ||||||
24 | Physician Assistant Practice Act of 1987, or an advanced | ||||||
25 | practice
nurse with prescriptive authority delegated under | ||||||
26 | Section 65-40 of the Nurse Practice Act and in accordance with |
| |||||||
| |||||||
1 | Section 303.05
and a written
collaborative agreement under | ||||||
2 | Section 65-35 of the Nurse Practice Act.
| ||||||
3 | (nn) "Prescription" means a lawful written, facsimile, or | ||||||
4 | verbal order
of
a physician licensed to practice medicine in | ||||||
5 | all its branches,
dentist, podiatrist or veterinarian for any | ||||||
6 | controlled
substance, of an optometrist for a Schedule III, IV, | ||||||
7 | or V controlled substance in accordance with Section 15.1 of | ||||||
8 | the Illinois Optometric Practice Act of 1987, of a physician | ||||||
9 | assistant for a Schedule III, IV, or V
controlled substance
in | ||||||
10 | accordance with Section 303.05 and the written guidelines | ||||||
11 | required under
Section 7.5 of the
Physician Assistant Practice | ||||||
12 | Act of 1987, or of an advanced practice
nurse with prescriptive | ||||||
13 | authority delegated under Section 65-40 of the Nurse Practice | ||||||
14 | Act who issues a prescription for a Schedule III, IV, or V
| ||||||
15 | controlled substance in accordance
with
Section 303.05 and a | ||||||
16 | written collaborative agreement under Section 65-35 of the | ||||||
17 | Nurse Practice Act.
| ||||||
18 | (oo) "Production" or "produce" means manufacture, | ||||||
19 | planting,
cultivating, growing, or harvesting of a controlled | ||||||
20 | substance other than methamphetamine.
| ||||||
21 | (pp) "Registrant" means every person who is required to | ||||||
22 | register
under Section 302 of this Act.
| ||||||
23 | (qq) "Registry number" means the number assigned to each | ||||||
24 | person
authorized to handle controlled substances under the | ||||||
25 | laws of the United
States and of this State.
| ||||||
26 | (rr) "State" includes the State of Illinois and any state, |
| |||||||
| |||||||
1 | district,
commonwealth, territory, insular possession thereof, | ||||||
2 | and any area
subject to the legal authority of the United | ||||||
3 | States of America.
| ||||||
4 | (ss) "Ultimate user" means a person who lawfully possesses | ||||||
5 | a
controlled substance for his own use or for the use of a | ||||||
6 | member of his
household or for administering to an animal owned | ||||||
7 | by him or by a member
of his household.
| ||||||
8 | (Source: P.A. 94-556, eff. 9-11-05; 95-242, eff. 1-1-08; | ||||||
9 | 95-639, eff. 10-5-07; 95-689, eff. 10-29-07; 95-876, eff. | ||||||
10 | 8-21-08.)
| ||||||
11 | (720 ILCS 570/303.05)
| ||||||
12 | Sec. 303.05. Mid-level practitioner registration.
| ||||||
13 | (a) The Department of Financial and Professional | ||||||
14 | Regulation shall register licensed
physician assistants and | ||||||
15 | licensed advanced practice nurses to prescribe and
dispense | ||||||
16 | Schedule
II, III, IV, or V controlled substances under Section | ||||||
17 | 303 and euthanasia
agencies to purchase, store, or administer | ||||||
18 | euthanasia drugs under the
following circumstances:
| ||||||
19 | (1) with respect to physician assistants or advanced | ||||||
20 | practice nurses,
| ||||||
21 | (A) the physician assistant or advanced practice | ||||||
22 | nurse has been
delegated
prescriptive authority by a | ||||||
23 | physician licensed to practice medicine in all its
| ||||||
24 | branches in accordance with Section 7.5 of the | ||||||
25 | Physician Assistant Practice Act
of 1987 or Section |
| |||||||
| |||||||
1 | 65-40 of the Nurse Practice Act;
and
| ||||||
2 | (B) the physician assistant or advanced practice | ||||||
3 | nurse has
completed the
appropriate application forms | ||||||
4 | and has paid the required fees as set by rule;
or
| ||||||
5 | (2) with respect to euthanasia agencies, the | ||||||
6 | euthanasia agency has
obtained a license from the | ||||||
7 | Department of
Professional Regulation and obtained a | ||||||
8 | registration number from the
Department.
| ||||||
9 | (b) The mid-level practitioner shall only be licensed to | ||||||
10 | prescribe those
schedules of controlled substances for which a | ||||||
11 | licensed physician has delegated
prescriptive authority, | ||||||
12 | except that a euthanasia agency does not have any
prescriptive | ||||||
13 | authority.
| ||||||
14 | (c) Upon completion of all registration requirements, | ||||||
15 | physician
assistants, advanced practice nurses, and euthanasia | ||||||
16 | agencies shall be issued a
mid-level practitioner
controlled | ||||||
17 | substances license for Illinois.
| ||||||
18 | (Source: P.A. 95-639, eff. 10-5-07.)
|